To better understand the potential downstream molecular mechanism of CHD1L in drug resistance, a Cancer Drug Resistance Real-time PCR Array containing 84 well-known drug resistance-related genes was used to compare mRNA expression profiles between A549-CHD1L cells and those of control A549-vector cells. This evidence concerns the gene CHD1L and cancer.